Aim: Asthma is an allergic disease causing mucus secretion, release various pro-inflammatory mediators such as tumor necrosis factor-α (TNF-α) and interleukins. The aim of this study was to evaluate the effect of thymoquinone (TQ) on allergic airway inflammation in rats. Methods: Allergic airway inflammation induced by ovalbumin (OVA) challenge in sensitized-rats and effect of TQ were studied. Inflammatory cells, interleukin (IL)-6 and TNF-α in bronchoalveolar lavage (BAL) fluid, and lipid peroxidation (LPO) in lung tissue were measured. Microvascular leakage was detected by Evans blue dye leakage in airway tissues. Results: Tidal volume was significantly lower in OVA group (1.4± 0.07 ml) than control group (1.9±0.04 ml) (p = 0.002), while breathing frequency was significantly higher in OVA group (135.3±12.9 min-1) than control group (p=0.017). In terms of tidal volume, statistical significance between TQ30 and OVA groups was found (1.8±0.07 ml) (p=0.008), while in terms of breathing frequency, no significance was found between both of them (126.7±7.3). Total white blood cell count was significantly higher in OVA group (1,376.8±136.4 x103/ml) than control group (545.0±106.7 x103/ml) (p<0.001). Statistical significance was found in TQ10 (824.7±4.5 x103/ml) group when compared OVA group (p=0.036), while statistical significance was not found in TQ1 group (1,282.2±137.7 x103/ml). When compared OVA group (60.3±4.9 pg/ml) with control group in terms of the TNF-α level, statistical significance was found (36.7± 4.7 pg/ml) (p=0.011). The Evans blue dye level was significantly higher in OVA group (31.8±3.6 ng/mg of tissue) than control (12.5±1.1 ng/mg of tissue) group (p<0.001), and TQ10 group (16.3±6.7 ng/mg of tissue) (p=0.002), and TQ30 (13.5±1.0 ng/mg of tissue) group (p<0.001). Conclusion: These findings reveal that TQ could be beneficial in asthma pathophysiology due to its immunomodulatory, anti-inflammatory, and antioxidant effects.